This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
R&D Systems
product type :
other
product name :
Simple Plex Control for Mouse CXCL2/GRO beta/MIP-2/CINC-3
catalog :
898306
quantity :
1 Each
price :
145 USD
product information
master code :
898306
SKU :
898306
product name :
Simple Plex Control for Mouse CXCL2/GRO beta/MIP-2/CINC-3
unit size :
1 Each
target :
CXCL2/GRO beta/MIP-2/CINC-3
category :
Simple Plex Assays
species :
Mouse
applications :
Control, Simple Plex Automated Immunoassay
extended description :
Control for use with Mouse CXCL2/GRO beta/MIP-2/CINC-3 Simple Plex Cartridge Kit
USD :
145 USD
product details :
Control for use with Mouse CXCL2/GRO beta/MIP-2/CINC-3 Simple Plex Cartridge Kit
alt names :
chemokine (C-X-C motif) ligand 2, CINC-2a, CINC3, CINC-3, C-X-C Motif Chemokine 2, GRO beta, GRO2, GRO2 oncogene, GROb, Gro-beta, Growth-regulated protein beta, Macrophage inflammatory protein 2-alpha, melanoma growth stimulatory activity beta, MGSA beta, MGSA-b, MGSA-beta, MIP2, MIP-2, MIP-2a, MIP2A, MIP2-alpha, SCYB2
storage :
Store lyophilized controls at 2-8 ░C. Lyophilized controls are stable for up to 12 months from date of receipt. Reconstituted controls are stable for up to 6 months from date of preparation when stored at <= -70 ░C. Storage at -20░ C is not recommended. Individual frozen aliquots of low and high controls are designed as single-use entities. Thaw directly before use and discard any remaining volume.
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
questions and comments
